Parkinson’s disease and apathy
Integrative Research Laboratories Sweden AB focuses on clinical research in Parkinson’s disease with a specific interest in apathy and reduced motivation. Its trial portfolio reflects attention to neuropsychiatric symptoms that affect daily functioning alongside the core movement disorder.
- Parkinson’s disease
- Apathy
- Motivational impairment
The sponsor’s research activity is centered on therapeutic approaches intended to address non-motor symptoms in people living with neurodegenerative disorders.
Neurodegenerative disorders
The sponsor also works within the broader field of neurodegenerative disorders, with research directed toward symptoms that can accompany progressive neurological disease. This includes clinical interest in behavioral and cognitive features linked to diminished initiative and engagement.
- Neurodegenerative disorders
- Non-motor symptoms
- Behavioral symptoms
Its funded studies place emphasis on treatment areas where neurological decline intersects with changes in mood, drive, and participation in everyday activities.
Clinical pharmacology and tolerability
Research activity includes early clinical evaluation of investigational therapy in healthy volunteers and in older adults, with attention to safety, tolerability, and pharmacokinetics. These studies support understanding of how the compound behaves in the body across different adult populations.
- Safety
- Tolerability
- Pharmacokinetics
The sponsor’s clinical work spans both general adult and healthy elderly populations, reflecting interest in age-related considerations for neurological therapeutics.
